Showing results (1141-1150 of 1,210) with videos related to

Sort By:
Pageof 121
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2022
Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional AssayChunling Hu, Lisa R Susswein, Maegan E Roberts, et al.
The Lancet. Oncology|April 22, 2014
Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 studyPippa G Corrie, Andrea Marshall, Janet A Dunn, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 29, 2024
Analysis of ASCL1/NEUROD1/POU2F3/YAP1 Yields Novel Insights for the Diagnosis of Olfactory Neuroblastoma and Identifies Sinonasal Tuft Cell-Like CarcinomaChristopher A Febres-Aldana, Mahmoud M Elsayad, Maelle Saliba, et al.
Journal of the National Cancer Institute|May 1, 2016
Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the OthersJohn M S Bartlett, Jane Bayani, Andrea Marshall, et al.
The Lancet. Oncology|April 1, 2021
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trialNancy Y Lee, Robert L Ferris, Amanda Psyrri, et al.
Trauma Surgery & Acute Care Open|August 16, 2021
Factors associated with receipt of intracranial pressure monitoring in older adults with traumatic brain injuryMira Ghneim, Jennifer Albrecht, Karen Brasel, et al.
Annals of Surgery|December 1, 2001
Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trialJ P Neoptolemos, D D Stocken, J A Dunn, et al.
Virchows Archiv : an International Journal of Pathology|August 17, 2024
What factors influence cellular pathologists' confidence in case reporting?Harriet Evans, Peter K Kimani, Louise Hiller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2015
Predicting Anthracycline Benefit: TOP2A and CEP17-Not Only but AlsoJohn M S Bartlett, Christopher C McConkey, Alison F Munro, et al.
The Journal of Trauma and Acute Care Surgery|October 24, 2022
Prospective validation and application of the Trauma-Specific Frailty Index: Results of an American Association for the Surgery of Trauma multi-institutional observational trialBellal Joseph, Abdul Tawab Saljuqi, Joseph D Amos, et al.
Pageof 121